Inactive Instrument
Peregrine Pharmaceuticals Share Price Nasdaq
Stocks
US7136613046
Pharmaceuticals
| Market Cap | 80Cr 69Cr 65Cr 59Cr 110.83Cr 7.63TCr 111.39Cr 774.09Cr 297.67Cr 3.88TCr 300.04Cr 293.45Cr 12TCr | P/E 2023 |
2,007x | P/E 2024 | -3.42x |
|---|---|---|---|---|---|
| Enterprise Value | 96Cr 83Cr 79Cr 71Cr 133.76Cr 9.21TCr 134.44Cr 934.28Cr 359.27Cr 4.69TCr 362.13Cr 354.18Cr 15TCr | EV / Sales 2023 |
8.58x | EV / Sales 2024 | 4.64x |
| Free-Float |
98.58% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -2.83% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 15/09/2025 | |
Richard McAvoy
DFI | Director of Finance/CFO | - | 01/06/2026 |
David Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | +7.69% | - | - | 80Cr | |
| -1.48% | -5.59% | +39.55% | -5.42% | 7.8TCr | |
| +5.38% | -1.09% | +512.38% | +32.58% | 5.75TCr | |
| +2.47% | -1.09% | -16.23% | -35.83% | 5.74TCr | |
| -0.56% | -2.21% | -11.34% | +27.29% | 4.88TCr | |
| +1.93% | -2.37% | -0.87% | +151.53% | 4.55TCr | |
| +0.80% | -1.67% | +49.90% | -15.15% | 3.21TCr | |
| -1.47% | -4.17% | +46.17% | +92.50% | 2.46TCr | |
| +2.14% | -5.58% | +0.05% | +153.38% | 2.08TCr | |
| -0.09% | -3.61% | +62.49% | +99.45% | 1.57TCr | |
| Average | +0.64% | -3.87% | +75.79% | +55.59% | 4.23TCr | |
| Weighted average by Cap. | +1.13% | -3.71% | +91.30% | +37.23% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 144.63Cr 56Cr 725.5Cr 56Cr 55Cr 2.29TCr | 14Cr 12Cr 11Cr 10Cr 19Cr 1.34TCr 20Cr 135.57Cr 52Cr 680.03Cr 53Cr 51Cr 2.15TCr |
| Net income | 6L 5L 5L 4L 8L 5.35Cr 8L 54.26L 20.87L 2.72Cr 21.03L 20.57L 8.6Cr | -14Cr -12Cr -11Cr -10Cr -20Cr -1.34TCr -20Cr -136.38Cr -52Cr -684.12Cr -53Cr -52Cr -2.16TCr |
| Net Debt | 15Cr 13Cr 12Cr 11Cr 21Cr 1.44TCr 21Cr 146.53Cr 56Cr 735Cr 57Cr 56Cr 2.32TCr | 17Cr 14Cr 13Cr 12Cr 23Cr 1.58TCr 23Cr 160.19Cr 62Cr 803.56Cr 62Cr 61Cr 2.54TCr |
Employees
-
Sector
Pharmaceuticals
